Put on watch> Threshold Pharmaceuticals, In (THLD)
Post# of 23094
Posted On: 12/07/2015 6:58:36 PM
Put on watch> Threshold Pharmaceuticals, In (THLD)
$ 0.60 ▼-2.74 ( -82.04% )
Volume: 33,177,728
UPDATE: Threshold Pharmaceuticals' stock plunges after drug trial disappoints
7 hours 56 minutes ago - DJNF
By Tomi Kilgore, MarketWatch
Stock hits 7-year low, as volume spikes to 24 times the full-day average in the first 90 minutes of trade
Threshold Pharmaceuticals Inc.'s stock plunged in very active trade to a seven-year low Monday, after two late-stage trials of its investigational cancer treatment failed to meet their primary endpoints.
The stock (THLD) slid as much as 85% early in the session to an intraday low of 51 cents, which was the lowest price seen since Dec. 24, 2008. Volume in the first 90 minutes of trade was 19.5 million shares, or about 24 times the full-day average of about 803,495 shares, according to FactSet.
(https://w.graphiq.com/w/ke7sVtn644Z)
The company said early Monday that one Phase 3 study of evofosfamide, in patients with previously untreated metastatic pancreatic cancer, did not demonstrate a statistically-significant improvement in overall survival when compared with a placebo. Another Phase 3 trial didn't show a statistically-significant improvement in overall survival when compared with doxorubicin, a medication used in chemotherapy.
"We are surprised and disappointed that these studies did not show that evofosfamide could extend the lives of patients with these two difficult-to-treat diseases," said Chief Executive Barry Selick. "While we believe there remains substantial data to support the role of hypoxia in cancer treatment resistance, we are deeply frustrated with our inability in these trials to impact that in a meaningful way.
Prior to Monday's selloff, the Threshold's stock had gained 5% year to date, while the S&P 500 had tacked on 1.6%.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
December 07, 2015 11:04 ET (16:04 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
$ 0.60 ▼-2.74 ( -82.04% )
Volume: 33,177,728
UPDATE: Threshold Pharmaceuticals' stock plunges after drug trial disappoints
7 hours 56 minutes ago - DJNF
By Tomi Kilgore, MarketWatch
Stock hits 7-year low, as volume spikes to 24 times the full-day average in the first 90 minutes of trade
Threshold Pharmaceuticals Inc.'s stock plunged in very active trade to a seven-year low Monday, after two late-stage trials of its investigational cancer treatment failed to meet their primary endpoints.
The stock (THLD) slid as much as 85% early in the session to an intraday low of 51 cents, which was the lowest price seen since Dec. 24, 2008. Volume in the first 90 minutes of trade was 19.5 million shares, or about 24 times the full-day average of about 803,495 shares, according to FactSet.
(https://w.graphiq.com/w/ke7sVtn644Z)
The company said early Monday that one Phase 3 study of evofosfamide, in patients with previously untreated metastatic pancreatic cancer, did not demonstrate a statistically-significant improvement in overall survival when compared with a placebo. Another Phase 3 trial didn't show a statistically-significant improvement in overall survival when compared with doxorubicin, a medication used in chemotherapy.
"We are surprised and disappointed that these studies did not show that evofosfamide could extend the lives of patients with these two difficult-to-treat diseases," said Chief Executive Barry Selick. "While we believe there remains substantial data to support the role of hypoxia in cancer treatment resistance, we are deeply frustrated with our inability in these trials to impact that in a meaningful way.
Prior to Monday's selloff, the Threshold's stock had gained 5% year to date, while the S&P 500 had tacked on 1.6%.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
December 07, 2015 11:04 ET (16:04 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'